期刊文献+

Ste20-related proline/alanine-rich kinase:A novel regulator of intestinal inflammation

Ste20-related proline/alanine-rich kinase:A novel regulator of intestinal inflammation
下载PDF
导出
摘要 Recently, inflammatory bowel disease (IBD) has been the subject of considerable research, with increasing attention being paid to the loss of intestinal epithelial cell barrier function as a mechanism of pathogenesis. Ste20-related proline/alanine-rich kinase (SPAK) is involved in regulating barrier function. SPAK is known to interact with inflammation-related kinases (such as p38, JNK, NKCC1, PKCS, WNK and MLCK), and with transcription factor AP-1, resulting in diverse biological phenomena, including cell differentiation, cell transformation and proliferation, cytoskeleton rearrangement, and regulation of chloride transport. This review examines the involvement of Ste20-1ike kinases and downstream mitogen-activated protein kinases (MAPKs) pathways in the pathogenesis and control of intestinal inflammation. The primary focus will be on the molecular features of intestinal inflammation, with an emphasis on the interaction between SPAK and other molecules, and the effect of these interactions on homeostatic maintenance, cell volume regulation and increased cell permeability in intestinal inflammation. Recently,inflammatory bowel disease (IBD) has been the subject of considerable research,with increasing attention being paid to the loss of intestinal epithelial cell barrier function as a mechanism of pathogenesis.Ste20-related proline/alanine-rich kinase (SPAK) is involved in regulating barrier function.SPAK is known to interact with inflammation-related kinases (such as p38,JNK,NKCC1,PKCθ,WNK and MLCK),and with transcription factor AP-1,resulting in diverse biological phenomena,including cell differentiation,cell transformation and proliferation,cytoskeleton rearrangement,and regulation of chloride transport.This review examines the involvement of Ste20-like kinases and downstream mitogen-activated protein kinases (MAPKs) pathways in the pathogenesis and control of intestinal inflammation.The primary focus will be on the molecular features of intestinal inflammation,with an emphasis on the interaction between SPAK and other molecules,and the effect of these interactions on homeostatic maintenance,cell volume regulation and increased cell permeability in intestinal inflammation.
作者 Didier Merlin
机构地区 Department of Medicine
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第40期6115-6121,共7页 世界胃肠病学杂志(英文版)
关键词 Inflammatory bowel diseases WNK NKCCl Barrier function Ste20-related proline/alanine-rich kinase 肠疾病 WNK NKCCl 屏障功能 肠炎
  • 相关文献

参考文献81

  • 1[1]Gaudier E,Michel C,Segain JP,Cherbut C,Hoebler C.The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice.J Nutr 2005; 135:2753-2761
  • 2[2]Goyette P,Labbe C,Trinh TT,Xavier RJ,Rioux JD.Molecular pathogenesis of inflammatory bowel disease:genotypes,phenotypes and personalized medicine.Ann Med 2007; 39:177-199
  • 3[3]Lievin-Le Moal V,Servin AL.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms:mucins,antimicrobial peptides,and microbiota.Clin Microbiol Rev 2006; 19:315-337
  • 4[4]Hugot JP,Laurent-Puig P,Gower-Rousseau C,Olson JM,Lee JC,Beaugerie L,Naom I,Dupas JL,Van Gossum A,Orholm M,Bonaiti-Pellie C,Weissenbach J,Mathew CG,Lennard-Jones JE,Cortot A,Colombel JF,Thomas G.Mapping of a susceptibility locus for Crohn's disease on chromosome 16.Nature 1996; 379:821-823
  • 5[5]Satsangi J,Parkes M,Louis E,Hashimoto L,Kato N,Welsh K,Terwilliger JD,Lathrop GM,Bell JI,Jewell DP.Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3,7 and 12.Nat Genet 1996; 14:199-202
  • 6[6]van Heel DA,Fisher SA,Kirby A,Daly MJ,Rioux JD,Lewis CM.Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs.Hum Mol Genet 2004; 13:763-770
  • 7[7]Peltekova VD,Wintle RF,Rubin LA,Amos CI,Huang Q,Gu X,Newman B,Van Oene M,Cescon D,Greenberg G,Griffiths AM,St George-Hyslop PH,Siminovitch KA.Functional variants of OCTN cation transporter genes are associated with Crohn disease.Nat Genet 2004; 36:471-475
  • 8[8]Hampe J,Franke A,Rosenstiel P,Till A,Teuber M,Huse K,Albrecht M,Mayr G,De La Vega FM,Briggs J,Gunther S,Prescott NJ,Onnie CM,Hasler R,Sipos B,Folsch UR,Lengauer T,Platzer M,Mathew CG,Krawczak M,Schreiber S.A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.Nat Genet 2007; 39:207-211
  • 9[9]Hampe J,Shaw SH,Saiz R,Leysens N,Lantermann A,Mascheretti S,Lynch NJ,MacPherson AJ,Bridger S,van Deventer S,Stokkers P,Morin P,Mirza MM,Forbes A,Lennard-Jones JE,Mathew CG,Curran ME,Schreiber S.Linkage of inflammatory bowel disease to human chromosome 6p.Am J Hum Genet 1999; 65:1647-1655
  • 10[10]Stoll M,Corneliussen B,Costello CM,Waetzig GH,Mellgard B,Koch WA,Rosenstiel P,Albrecht M,Croucher PJ,Seegert D,Nikolaus S,Hampe J,Lengauer T,PierrouS,Foelsch UR,Mathew CG,Lagerstrom-Fermer M,Schreiber S.Genetic variation in DLG5 is associated with inflammatory bowel disease.Nat Genet 2004; 36:476-480

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部